2019 |
09/06 | 11:30 当社子会社によるRoivant Sciencesとの戦略的提携に関する基本合意書の締結について |
09/04 | 466 | 467 | 461 | 464 | -1.07% | 4,410,800 | 7681億2702万 | -0.43% |
09/03 | 466 | 472 | 465 | 469 | +1.08% | 4,588,000 | 7764億425万 | +0.43% |
09/02 | 460 | 465 | 460 | 464 | -0.22% | 4,246,000 | 7681億2702万 | -0.85% |
08/30 | 463 | 466 | 460 | 465 | +1.09% | 6,774,600 | 7697億8247万 | -0.85% |
08/29 | 460 | 462 | 456 | 460 | -0.22% | 4,163,100 | 7615億524万 | -2.13% |
08/28 | 460 | 464 | 456 | 461 | +0.66% | 6,060,500 | 7631億6068万 | -2.33% |
08/27 | 463 | 467 | 455 | 458 | 0% | 9,450,200 | 7581億9434万 | -3.17% |
08/26 | 449 | 460 | 448 | 458 | -1.29% | 9,123,100 | 7581億9434万 | -3.38% |
08/23 | 468 | 469 | 463 | 464 | -0.22% | 5,069,200 | 7681億2702万 | -2.32% |
08/22 | 466 | 467 | 463 | 465 | +0.43% | 4,882,000 | 7697億8247万 | -2.31% |
08/21 | 463 | 467 | 460 | 463 | -1.07% | 4,249,100 | 7664億7157万 | -2.94% |
08/20 | 467 | 470 | 464 | 468 | +0.43% | 4,988,900 | 7747億4881万 | -2.09% |
08/19 | 467 | 472 | 464 | 466 | +1.08% | 6,968,700 | 7714億3791万 | -2.71% |
08/16 | 454 | 462 | 453 | 461 | +0.44% | 6,282,000 | 7631億6068万 | -3.96% |
08/15 | 452 | 461 | 450 | 459 | -1.5% | 7,612,900 | 7598億4979万 | -4.57% |
08/14 | 461 | 468 | 460 | 466 | +2.87% | 9,657,300 | 7714億3791万 | -3.32% |
08/13 | 454 | 455 | 450 | 453 | -2.37% | 7,685,000 | 7499億1711万 | -6.4% |
08/09 | 464 | 466 | 458 | 464 | +0.87% | 7,353,100 | 7681億2702万 | -4.53% |
08/08 | 457 | 461 | 452 | 460 | +0.22% | 7,949,300 | 7615億524万 | -5.74% |
08/07 | 461 | 463 | 456 | 459 | -0.86% | 7,227,500 | 7598億4979万 | -6.33% |
08/06 | 446 | 463 | 443 | 463 | +0.43% | 12,086,500 | 7664億7157万 | -5.89% |
08/05 | 466 | 466 | 452 | 461 | -2.74% | 12,602,400 | 7631億6068万 | -6.68% |
08/02 | 486 | 486 | 473 | 474 | -5.39% | 13,582,600 | 7846億8148万 | -4.44% |
08/01 | 491 | 504 | 490 | 501 | +0.2% | 8,969,400 | 8293億7853万 | +0.8% |
07/31 | 15:30 2020年3月期第1四半期決算短信〔IFRS〕(連結) |
07/31 | 492 | 501 | 492 | 500 | +1.01% | 7,430,600 | 8277億2308万 | +0.81% |
07/30 | 490 | 498 | 490 | 495 | +1.23% | 6,275,400 | 8194億4585万 | -0.2% |
07/29 | 490 | 490 | 483 | 489 | 0% | 6,451,700 | 8095億1318万 | -1.41% |
07/26 | 492 | 495 | 488 | 489 | -1.01% | 6,162,400 | 8095億1318万 | -1.21% |
07/25 | 499 | 499 | 492 | 494 | -0.6% | 4,388,900 | 8177億9041万 | -0.2% |
07/24 | 498 | 500 | 495 | 497 | +0.2% | 5,014,000 | 8227億5674万 | +0.4% |
07/23 | 490 | 499 | 487 | 496 | +1.02% | 6,045,700 | 8211億130万 | +0.4% |
07/22 | 490 | 495 | 489 | 491 | +0.82% | 4,401,300 | 8128億2407万 | -0.41% |
07/19 | 480 | 489 | 477 | 487 | +1.46% | 5,107,700 | 8062億228万 | -1.22% |
07/18 | 485 | 491 | 478 | 480 | -2.24% | 7,144,800 | 7946億1416万 | -2.64% |
07/17 | 485 | 493 | 483 | 491 | +0.41% | 5,888,400 | 8128億2407万 | -0.41% |
07/16 | 488 | 490 | 485 | 489 | -0.81% | 4,616,500 | 8095億1318万 | -0.81% |
07/12 | 492 | 496 | 490 | 493 | +0.41% | 3,907,500 | 8161億3496万 | 0% |
07/11 | 483 | 492 | 481 | 491 | +1.66% | 5,424,900 | 8128億2407万 | -0.41% |
07/10 | 490 | 491 | 483 | 483 | -2.42% | 10,639,400 | 7995億8050万 | -1.83% |
07/09 | 499 | 507 | 495 | 495 | -2.75% | 8,136,700 | 8194億4585万 | +0.61% |
07/08 | 514 | 516 | 509 | 509 | -0.39% | 4,958,700 | 8426億2210万 | +3.67% |
07/05 | 513 | 515 | 511 | 511 | 0% | 3,834,000 | 8459億3299万 | +4.5% |
07/04 | 508 | 514 | 508 | 511 | +1.19% | 4,827,500 | 8459億3299万 | +4.71% |
07/03 | 508 | 509 | 502 | 505 | -1.75% | 6,450,400 | 8360億31万 | +3.7% |
07/02 | 13:00 当社子会社による開発中の抗がん剤ナパブカシンの膵がんを対象としたフェーズ3試験(CanStem111P試験)の中止について |
07/02 | 514 | 516 | 511 | 514 | -0.19% | 5,215,100 | 8508億9933万 | +5.98% |
07/01 | 509 | 516 | 503 | 515 | +3% | 7,603,600 | 8525億5478万 | +6.4% |
06/28 | 503 | 503 | 496 | 500 | +0.2% | 7,410,100 | 8277億2308万 | +3.52% |
06/27 | 486 | 500 | 485 | 499 | +3.31% | 8,573,500 | 8260億6764万 | +3.53% |
06/26 | 483 | 486 | 479 | 483 | -0.62% | 6,904,300 | 7995億8050万 | +0.42% |
06/25 | 491 | 492 | 485 | 486 | -0.82% | 6,108,100 | 8045億4684万 | +1.04% |
06/24 | 490 | 491 | 486 | 490 | +0.41% | 4,346,800 | 8111億6862万 | +1.66% |
06/21 | 483 | 492 | 482 | 488 | +0.83% | 9,362,500 | 8078億5773万 | +1.24% |
06/20 | 487 | 487 | 479 | 484 | -0.62% | 9,064,300 | 8012億3594万 | +0.41% |
06/19 | 483 | 488 | 478 | 487 | +2.53% | 7,928,400 | 8062億228万 | +0.83% |
06/18 | 479 | 481 | 473 | 475 | -1.04% | 6,801,300 | 7863億3693万 | -1.86% |
06/17 | 480 | 484 | 478 | 480 | -0.41% | 6,852,900 | 7946億1416万 | -1.23% |
06/14 | 481 | 485 | 478 | 482 | -0.41% | 5,988,400 | 7979億2505万 | -0.82% |
06/13 | 487 | 491 | 481 | 484 | -1.22% | 6,299,200 | 8012億3594万 | -0.82% |
06/12 | 488 | 495 | 486 | 490 | -0.2% | 5,752,100 | 8111億6862万 | +0.2% |
06/11 | 485 | 494 | 484 | 491 | +1.03% | 5,410,400 | 8128億2407万 | +0.2% |
06/10 | 487 | 490 | 483 | 486 | +1.25% | 5,723,800 | 8045億4684万 | -1.22% |
06/07 | 477 | 481 | 474 | 480 | +0.63% | 4,815,300 | 7946億1416万 | -3.03% |
06/06 | 476 | 478 | 474 | 477 | -0.83% | 5,989,300 | 7896億4782万 | -4.02% |
06/05 | 480 | 484 | 476 | 481 | +1.91% | 7,795,500 | 7962億6961万 | -3.8% |
06/04 | 470 | 472 | 465 | 472 | +1.51% | 7,431,400 | 7813億7059万 | -5.98% |
06/03 | 464 | 470 | 462 | 465 | -1.06% | 7,114,000 | 7697億8247万 | -7.92% |
05/31 | 477 | 480 | 470 | 470 | -2.69% | 10,307,100 | 7780億5970万 | -7.66% |
05/30 | 474 | 484 | 473 | 483 | +1.68% | 5,760,200 | 7995億8050万 | -5.66% |
05/29 | 469 | 478 | 468 | 475 | 0% | 8,636,100 | 7863億3693万 | -7.59% |
05/28 | 476 | 481 | 474 | 475 | -1.04% | 9,167,500 | 7863億3693万 | -8.12% |
05/27 | 484 | 486 | 479 | 480 | -1.23% | 4,567,000 | 7946億1416万 | -7.69% |
05/24 | 474 | 487 | 464 | 486 | +1.67% | 10,085,900 | 8045億4684万 | -6.9% |
05/23 | 484 | 484 | 475 | 478 | -2.25% | 7,154,300 | 7913億327万 | -8.78% |
05/22 | 492 | 496 | 486 | 489 | -0.61% | 5,832,200 | 8095億1318万 | -7.03% |
05/21 | 486 | 494 | 480 | 492 | -0.4% | 8,418,900 | 8144億7951万 | -6.82% |
05/20 | 500 | 500 | 489 | 494 | -1.98% | 7,241,300 | 8177億9041万 | -6.79% |
05/17 | 511 | 512 | 503 | 504 | 0% | 5,295,500 | 8343億4487万 | -5.26% |
05/16 | 500 | 514 | 494 | 504 | -2.14% | 9,521,200 | 8343億4487万 | -5.44% |
05/15 | 15:30 代表取締役の異動に関するお知らせ |
05/15 | 15:30 2019年3月期決算短信〔IFRS〕(連結) |
05/15 | 511 | 518 | 509 | 515 | +1.98% | 8,005,200 | 8525億5478万 | -3.74% |
05/14 | 493 | 506 | 487 | 505 | +0.4% | 8,221,700 | 8360億31万 | -5.61% |
05/13 | 504 | 505 | 502 | 503 | -1.95% | 6,151,900 | 8326億8942万 | -6.16% |
05/10 | 514 | 521 | 508 | 513 | -0.19% | 8,857,800 | 8492億4388万 | -4.47% |
05/09 | 517 | 520 | 511 | 514 | -1.15% | 7,907,600 | 8508億9933万 | -4.28% |
05/08 | 525 | 527 | 517 | 520 | -3.35% | 9,850,400 | 8608億3201万 | -3.17% |
05/07 | 551 | 552 | 535 | 538 | -2.54% | 9,041,000 | 8906億3004万 | 0% |
04/26 | 540 | 554 | 536 | 552 | +1.66% | 9,332,600 | 9138億628万 | +2.79% |
04/25 | 15:00 通期業績予想の修正に関するお知らせ |
04/25 | 544 | 546 | 536 | 543 | +0.37% | 5,773,900 | 8989億727万 | +1.12% |
04/24 | 550 | 552 | 539 | 541 | -1.28% | 7,268,300 | 8955億9638万 | +0.93% |
04/23 | 549 | 552 | 546 | 548 | +0.18% | 5,493,300 | 9071億8450万 | +2.24% |
04/22 | 547 | 551 | 543 | 547 | -0.18% | 3,174,000 | 9055億2905万 | +2.05% |
04/19 | 553 | 554 | 545 | 548 | +0.55% | 3,755,700 | 9071億8450万 | +2.24% |
04/18 | 545 | 556 | 542 | 545 | 0% | 8,044,000 | 9022億1816万 | +1.87% |
04/17 | 541 | 548 | 541 | 545 | +0.55% | 5,049,600 | 9022億1816万 | +1.87% |
04/16 | 541 | 546 | 540 | 542 | -0.37% | 4,170,800 | 8972億5182万 | +1.31% |
04/15 | 543 | 547 | 540 | 544 | +2.06% | 7,311,800 | 9005億6272万 | +1.87% |
04/12 | 532 | 536 | 527 | 533 | +0.19% | 5,309,400 | 8823億5281万 | 0% |
04/11 | 527 | 534 | 524 | 532 | 0% | 5,266,400 | 8806億9736万 | -0.19% |
04/10 | 527 | 535 | 522 | 532 | -1.12% | 7,093,400 | 8806億9736万 | -0.19% |
04/09 | 538 | 541 | 534 | 538 | -0.55% | 5,419,800 | 8906億3004万 | +0.75% |
04/08 | 550 | 552 | 541 | 541 | -1.46% | 5,247,600 | 8955億9638万 | +1.31% |